CompBrief BY VELARION

Companies Definitive Healthcare Corp.

Definitive Healthcare (DH): executive pay, fiscal 2025

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Definitive Healthcare Corp.’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.
CEO total pay$8,604,138CEO Kevin Coop · source
Say-on-pay support89.55%Latest vote · source
CEO vs. named peers63rd pct.Against its disclosed peer group

CEO pay, last three years

  • $10,876,456FY2024
  • $8,604,138FY2025

CEO total pay was $8,604,138 in fiscal 2025, down from $10,876,456 in fiscal 2024.

FY2025: salary $500,000 · bonus $0 · stock awards $7,696,741 · option awards $0

Executives and directors

Frequently asked questions

Who was the highest-paid executive at Definitive Healthcare Corp. in fiscal 2025?
As disclosed, Kevin Coop (Chief Executive Officer) was the highest-paid executive at Definitive Healthcare Corp. in fiscal 2025, with total compensation of $8,604,138.
How does Definitive Healthcare Corp.'s chief executive pay compare to its disclosed peer group?
As disclosed, Kevin Coop's total compensation ranked at the 63rd percentile of Definitive Healthcare Corp.'s disclosed peer group.
How did shareholders vote on Definitive Healthcare Corp.'s executive compensation?
As disclosed, 89.55% of shareholders supported Definitive Healthcare Corp.'s executive compensation in the latest say-on-pay vote.
How much does Definitive Healthcare Corp. spend in total on board compensation for fiscal 2025?
As disclosed, Definitive Healthcare Corp. reported total board compensation of $2,078,113 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Kevin Coop$500,000$0$7,696,741$0$384,875$0$22,522$8,604,138
Chief Executive Officer
Casey Heller362,30803,451,6220146,078014,2283,974,236
Chief Financial Officer
Benjamin Graboske318,36620,0002,881,8740185,120011,7753,417,135
EVP Technology and Engineering, Chief Data Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Kevin Coop$8,604,138$10,876,456—↓ −2,272,318
Casey Heller3,974,236———
Benjamin Graboske3,417,135———

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

Definitive Healthcare s executive compensation philosophy is based on total direct compensation--base salary, annual cash incentives, and long-term equity incentives--designed to attract and retain executive talent, reward achievement of financial and strategic objectives, and align executives interests with stockholders. The HCM & Compensation Committee oversees this program using its judgment, considers peer/market data and CEO recommendations (other than for the CEO), and generally seeks a mix in which long-term equity represents a substantial majority of target compensation.

CEO STI target (% of salary)100%
CEO LTI target (% of salary)—
Independent consultant—
Clawback policyTrue
Anti-hedgingtrue
Anti-pledgingtrue
Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Kevin CoopPRSU—————$7,696,741
Casey HellerPRSU—————3,451,622
Benjamin GraboskePRSU—————2,881,874

Vehicle mix — grant-date fair value by award type

Grant-level vehicle detail not disclosed.

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Casey HellerRSU11,166—$32,046
Casey HellerRSU18,088—51,913
Casey HellerRSU28,281—81,166
Kevin CoopRSU128,007—367,380
Casey HellerPSU261,628—750,872
Casey HellerRSU485,881—1,394,478
Casey HellerRSU498,339—1,430,233
Kevin CoopRSU804,408—2,308,651
Kevin CoopPSU1,137,038—3,263,299
Kevin CoopPSU1,283,096—3,682,486
Kevin CoopRSU2,382,892—6,838,900
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Jason KrantzEmployee director · Board Chair—$477,614$0—$61,371$538,985
Kathleen WintersIndependent · Audit175,000199,04300—374,043
Sastry ChilukuriIndependent · Audit · Nominating and Corporate Governance175,000199,04300—374,043
Samuel A. HamoodIndependent · Audit (Chair)70,000199,04300—269,043
Jill LarsenIndependent · HCM and Compensation (Chair) · Departed during FY70,000199,04300—269,043
Scott StephensonIndependent · HCM and Compensation (Chair) · Nominating and Corporate Governance53,913199,04300—252,956
Christopher EganNot independent000000
Lauren YoungIndependent · HCM and Compensation · Nominating and Corporate Governance (Chair)000000
Kevin CoopEmployee director000—00
Jeff HaywoodIndependent · HCM and Compensation000000

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer$175,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)20,000 / 20,000 / 10,000
Stock ownership guideline$150,000

Total cost of the board

ComponentFY2025
Cash retainers and fees$543,913
Equity awards (grant-date value)$1,472,829
All other compensation$61,371
Total cost of the board$2,078,113

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Definitive Healthcare as a peer

Companies that benchmark against DH

6 companies name DH as a compensation peer

Each company listed discloses DH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named DH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Definitive Healthcare Corp.2025Kevin Coop$500,000$7,696,741$0$384,875$8,604,138

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-04108,811,27112,680,71919,22389.55%Passed
20252025-06-05108,597,11112,910,917167,62489.25%Passed
20242024-05-22141,376,7633,663,2028,34697.47%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20262026-06-0489.55%a
20252025-06-0589.25%b
20242024-05-2297.47%c

a. Approved under the standard stated in the filing — “2), you may vote "FOR," "AGAINST," or "ABSTAIN." Abstentions will have the same effect as a vote "AGAINST" Proposal No.”.

b. Approved under the standard stated in the filing — “2), you may vote "FOR," "AGAINST," or "ABSTAIN." Abstentions will have the same effect as a vote "AGAINST" Proposal No.”.

c. Approved under the standard stated in the filing — “2), you may vote "FOR," "AGAINST," or "ABSTAIN." Abstentions will have the same effect as a vote "AGAINST" Proposal No.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)—
CEO total compensation—
Median employee compensation—
Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Casey HellerChief Financial Officer2026-05-01D1,469$1$1,454CommonForm 4 ↗
Jason KrantzDirector2026-05-01D12,166112,044CommonForm 4 ↗
Kevin CoopDirector2026-06-01D66,050165,390CommonForm 4 ↗
Casey HellerChief Financial Officer2026-06-01D164,3771162,733CommonForm 4 ↗
Sastry ChilukuriDirector2026-06-04A189,19000CommonForm 4 ↗
Kathleen WintersDirector2026-06-04A189,19000CommonForm 4 ↗
Scott StephensonDirector2026-06-04A189,19000CommonForm 4 ↗
Samuel A. HamoodDirector2026-06-04A189,19000CommonForm 4 ↗
Jonathan ParisChief Legal Officer2026-07-01D30,591124,473CommonForm 4 ↗
Kevin CoopDirector2026-07-01D37,593130,074CommonForm 4 ↗
Jason KrantzDirector2026-08-01D12,16618,301CommonForm 4 ↗
Casey HellerChief Financial Officer2026-08-01D1,88111,283CommonForm 4 ↗
Casey HellerChief Financial Officer2026-09-01D41,093137,078CommonForm 4 ↗
Casey HellerChief Financial Officer2026-10-01D12,542111,741CommonForm 4 ↗
Jonathan ParisChief Legal Officer2026-10-01D7,72917,235CommonForm 4 ↗
Clay Brian RitcheyDirector2026-10-23A2,626,26300CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

Sources (39 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Kevin Coop. DEF 14A, filed 2026-04-23. Section “Summary Compensation Table” · page 26. As printed: 8,604,138. View filing ↗
  • Section 01, Casey Heller. DEF 14A, filed 2026-04-23. Section “Summary Compensation Table” · page 26. As printed: 3,974,236. View filing ↗
  • Section 01, Benjamin Graboske. DEF 14A, filed 2026-04-23. Section “Summary Compensation Table” · page 26. As printed: 3,417,135. View filing ↗
  • Section 03, Kevin Coop PRSU. DEF 14A, filed 2026-04-23. Section “E XECUTIVE COMPENSATION TABLES” · grants of plan-based awards table. View filing ↗
  • Section 03, Casey Heller PRSU. DEF 14A, filed 2026-04-23. Section “E XECUTIVE COMPENSATION TABLES” · grants of plan-based awards table. View filing ↗
  • Section 03, Benjamin Graboske PRSU. DEF 14A, filed 2026-04-23. Section “E XECUTIVE COMPENSATION TABLES” · grants of plan-based awards table. View filing ↗
  • Section 07, pay ratio. 10-K, filed 2026-02-26. Section “CEO Pay Ratio”. As printed: —. View filing ↗
  • Section 08, Jason Krantz. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 538,985. View filing ↗
  • Section 08, Kathleen Winters. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 374,043. View filing ↗
  • Section 08, Sastry Chilukuri. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 374,043. View filing ↗
  • Section 08, Samuel A. Hamood. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 269,043. View filing ↗
  • Section 08, Jill Larsen. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 269,043. View filing ↗
  • Section 08, Scott Stephenson. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 252,956. View filing ↗
  • Section 08, Christopher Egan. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Lauren Young. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Kevin Coop. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Jeff Haywood. DEF 14A, filed 2026-04-23. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 02, Casey Heller 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jason Krantz 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kevin Coop 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casey Heller 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sastry Chilukuri 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kathleen Winters 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Stephenson 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Samuel A. Hamood 2026-06-04. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jonathan Paris 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kevin Coop 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jason Krantz 2026-08-01. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casey Heller 2026-08-01. Form 4, filed 2026-08-04. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casey Heller 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casey Heller 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jonathan Paris 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Clay Brian Ritchey 2026-10-23. Form 4, filed 2026-10-27. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 06, 2026 vote. Form 8-K, filed 2026-06-05. Item 5.07 · say-on-pay result. As reported: 89.55% (votes for as printed: 108,811,271). View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-06-06. Item 5.07 · say-on-pay result. As reported: 89.25% (votes for as printed: 108,597,111). View filing ↗
  • Section 06, 2024 vote. Form 8-K, filed 2024-05-24. Item 5.07 · say-on-pay result. As reported: 97.47% (votes for as printed: 141,376,763). View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 09b board cost (computed). Computed. Cash 543,913 + equity 1,472,829 + all other 61,371 = 2,078,113, summed across the director compensation table rows.
  • Definitive Healthcare Corp. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Definitive Healthcare Corp.'s own proxy. As printed: 8,604,138. View filing ↗
Get the full report — $500